Looking for a biopharma job in North Carolina? Check out the BioSpace list of seven companies hiring life sciences ...

A new report found that 85% of pharma respondents are increasing their artificial intelligence investments, and 70% see AI as an immediate priority. Two experts discuss how biopharmas are implementing ...

George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for ...

Susan Monarez is the first CDC director to be confirmed by the Senate under a new 2023 law and will be the first person ...

As analysts parsed news of Vinay Prasad’s ouster, worries over drug approval delays, cell and gene therapy impacts and more ...

CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for ...

Sarepta’s Elevidys is back on the market for ambulatory patients with Duchenne muscular dystrophy, Health Secretary Robert F. Kennedy Jr. reportedly plans to dissolve the U.S. Preventive Services Task ...

Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...

Though nerves abound for funders and founders in the industry, money continues to flow into startups, sometimes in ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...